Novo Nordisk(MX:NOVOBN)
MX$745.000.00 (0.00%)
MX:NOVOBN
Novo Nordisk earnings date
MX$745.00
At close:0.00 (0.00%)
Novo Nordisk (NOVOBN) Q2 2021 Earnings Report
2 Followers
MX:NOVOBN Q2 2021 EPS Results
- Actual EPS
- MXN 7.31
- Consensus EPS
- MXN 45.59
- Beat/Miss
- Missed by -MXN 38.28
- One Year Ago EPS
- MXN 6.30
MX:NOVOBN Q2 2021 Revenue Results
- Actual Revenue
- MXN 91.80B
- Expected Revenue
- MXN 601.67B
- Beat/Miss
- Missed by -MXN 509.87B
- YoY Revenue Growth
- +10.11%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/04/2021
- Time
- Before Open
- Conference Call
- Wednesday, August 4, 2021
MX:NOVOBN Upcoming Earnings
Novo Nordisk's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:NOVOBN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 12.53- | 16.78 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | 13.2116.09 | 12.5 | 28.67% (+3.58) | |
| Aug 04, 2026 | 2026 (Q2) | 13.9817.17 | 16.56 | 3.69% (+0.61) | |
| May 06, 2026 | 2026 (Q1) | 16.6618.42 | 18.14 | 1.53% (+0.28) | |
| Feb 03, 2026 | 2025 (Q4) | 16.3216.78 | 17.61 | -4.73% (-0.83) | |
| Nov 05, 2025 | 2025 (Q3) | 13.6112.50 | 17 | -26.47% (-4.50) | |
| Aug 06, 2025 | 2025 (Q2) | 16.4816.56 | 12.47 | 32.74% (+4.08) | |
| May 07, 2025 | 2025 (Q1) | 16.9618.14 | 15.78 | 14.96% (+2.36) | |
| Feb 05, 2025 | 2024 (Q4) | 16.6117.61 | 13.64 | 29.12% (+3.97) | |
| Nov 06, 2024 | 2024 (Q3) | 16.6617.00 | 13.89 | 22.40% (+3.11) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
